The 2019 novel coronavirus, SARS-CoV-2, producing the disease COVID-19 is a
pathogenic virus that targets mostly the human respiratory system and also other organs …

Recent Ebola virus disease epidemics have highlighted the need for effective vaccines and
therapeutics to prevent future outbreaks. Antibodies are clearly critical for control of this …

Zika virus (ZIKV), a mosquito-borne flavivirus, is a current global public health concern. The
flavivirus envelope (E) glycoprotein is responsible for virus entry and represents a major …

Ebola continues to rage in West Africa. In the absence of an approved vaccine or treatment,
the priority in controlling this epidemic is to promptly identify and isolate infected individuals …

Monoclonal antibodies can provide important pre-or post-exposure protection against
infectious disease for those not yet vaccinated or in individuals that fail to mount a protective …

Antibodies are promising post-exposure therapies against emerging viruses, but which
antibody features and in vitro assays best forecast protection are unclear. Our international …

Antibodies targeting the Ebola virus surface glycoprotein (EBOV GP) are implicated in
protection against lethal disease, but the characteristics of the human antibody response to …

Ebola virus (EBOV) remains a public health threat. We performed a longitudinal study of B
cell responses to EBOV in four survivors of the 2014 West African outbreak. Infection …

Abstract Background. The current West Africa Ebola virus disease (EVD) outbreak has
resulted in multiple individuals being medically evacuated to other countries for clinical …

ABSTRACT The Middle-East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic
virus that causes severe and often fatal respiratory disease in humans. Efforts to develop …